EUVIMEDOpdag EUVIMED
Crossref

Integrated untargeted and targeted testicular metabolomics to reveal the regulated mechanism of Gushudan on the hypothalamic‐pituitary‐gonadal axis of kidney‐yang‐deficiency‐syndrome rats

Yanwei Lou, Qinghua Liang, Ling Xin, Mengxin Ren, Qian Hang, Feng Qin iD, Zhili Xiong iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.5872 ↗

At a glance

Journal article in Biomedical Chromatography, 2024. Written by Yanwei Lou and 6 co-authors. Institution: School of Pharmacy, Shenyang Pharmaceutical University, Benxi, China. Major MEDLINE topics: Metabolomics, Yang Deficiency, Testis, Drugs, Chinese Herbal. Cited 1 times so far (Crossref); 38 references. Funded by: National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Modern studies have shown that neuroendocrine disorders caused by the dysfunction of the hypothalamic‐pituitary‐gonadal (HPG) axis are one of the important pathogenetic mechanisms of kidney‐yang‐deficiency‐syndrome (KYDS). The preventive effect of Gushudan on KYDS has been reported, but its regulatory mechanisms on the HPG axis have not been elucidated. In this study, we developed an integrated untargeted and targeted metabolomics analysis strategy to investigate the regulatory mechanism of Gushudan on the HPG axis in rats with KYDS. In untargeted metabolomics, we screened 14 potential biomarkers such as glycine, lysine, and glycerol that were significantly associated with the HPG axis. To explore the effect of changes in the levels of potential biomarkers on KYDS, all of them were quantified in targeted metabolomics. With the quantitative results, correlations between potential biomarkers and testosterone, a functional indicator of the HPG axis, were explored. The results showed that oxidative stress, inflammatory response, and energy depletion, induced by metabolic disorders in rats, were responsible for the decrease in testosterone levels. Gushudan improves metabolic disorders and restores testosterone levels, thus restoring HPG axis dysfunction. This finding elucidates the special metabolic characteristics of KYDS and the therapeutic mechanism of Gushudan from a new perspective.

Subjects

MeSH terms (MEDLINE)

MetabolomicsYang DeficiencyTestisDrugs, Chinese HerbalAnimalsMaleRatsRats, Sprague-DawleyHypothalamo-Hypophyseal SystemTestosteroneMetabolomeBiomarkersKidney DiseasesKidneyHypothalamic-Pituitary-Gonadal Axis

Author keywords

GC–MSblank matrixhypothalamic‐pituitary‐gonadal axiskidney‐yang‐deficiency‐syndromemetabolomic

Substances

Drugs, Chinese HerbalTestosteroneBiomarkers

Authors and institutions

  • School of Pharmacy, Shenyang Pharmaceutical University, Benxi, China.

ORCID profiles: Feng Qin, Zhili Xiong

Funding

  • National Natural Science Foundation of China

Cite

APA

Lou, Y., Liang, Q., Xin, L., Ren, M., Hang, Q., Qin, F., & Xiong, Z. (2024). Integrated untargeted and targeted testicular metabolomics to reveal the regulated mechanism of Gushudan on the hypothalamic‐pituitary‐gonadal axis of kidney‐yang‐deficiency‐syndrome rats. Biomedical Chromatography. https://doi.org/10.1002/bmc.5872

Vancouver

Lou Y, Liang Q, Xin L, Ren M, Hang Q, Qin F, et al. Integrated untargeted and targeted testicular metabolomics to reveal the regulated mechanism of Gushudan on the hypothalamic‐pituitary‐gonadal axis of kidney‐yang‐deficiency‐syndrome rats. Biomedical Chromatography. 2024. doi:10.1002/bmc.5872

BibTeX
@article{Lou2024,
  author = {Lou, Yanwei and Liang, Qinghua and Xin, Ling and Ren, Mengxin and Hang, Qian and Qin, Feng and Xiong, Zhili},
  title = {Integrated untargeted and targeted testicular metabolomics to reveal the regulated mechanism of Gushudan on the hypothalamic‐pituitary‐gonadal axis of kidney‐yang‐deficiency‐syndrome rats},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.5872}
}
Start for free →